JP2016540050A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016540050A5 JP2016540050A5 JP2016555933A JP2016555933A JP2016540050A5 JP 2016540050 A5 JP2016540050 A5 JP 2016540050A5 JP 2016555933 A JP2016555933 A JP 2016555933A JP 2016555933 A JP2016555933 A JP 2016555933A JP 2016540050 A5 JP2016540050 A5 JP 2016540050A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- moiety
- seq
- acid residues
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BBTRBXPZJTVATE-UHFFFAOYSA-N CCOCc1nc(c(N)nc2c3cccc2)c3[n]1C Chemical compound CCOCc1nc(c(N)nc2c3cccc2)c3[n]1C BBTRBXPZJTVATE-UHFFFAOYSA-N 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1321242.8A GB201321242D0 (en) | 2013-12-02 | 2013-12-02 | Immunogenic compound |
| GB1321242.8 | 2013-12-02 | ||
| PCT/GB2014/053577 WO2015082905A1 (en) | 2013-12-02 | 2014-12-02 | Immunogenic compound |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020185572A Division JP7095053B2 (ja) | 2013-12-02 | 2020-11-06 | 免疫原性化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016540050A JP2016540050A (ja) | 2016-12-22 |
| JP2016540050A5 true JP2016540050A5 (enExample) | 2018-01-25 |
| JP6792452B2 JP6792452B2 (ja) | 2020-11-25 |
Family
ID=49979653
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016555933A Expired - Fee Related JP6792452B2 (ja) | 2013-12-02 | 2014-12-02 | 免疫原性化合物 |
| JP2020185572A Expired - Fee Related JP7095053B2 (ja) | 2013-12-02 | 2020-11-06 | 免疫原性化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020185572A Expired - Fee Related JP7095053B2 (ja) | 2013-12-02 | 2020-11-06 | 免疫原性化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US9962453B2 (enExample) |
| EP (1) | EP3077052A1 (enExample) |
| JP (2) | JP6792452B2 (enExample) |
| KR (1) | KR102356869B1 (enExample) |
| CN (1) | CN105873638A (enExample) |
| BR (1) | BR112016012528A2 (enExample) |
| CA (1) | CA2931933A1 (enExample) |
| EA (1) | EA201691146A1 (enExample) |
| GB (1) | GB201321242D0 (enExample) |
| WO (1) | WO2015082905A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10801070B2 (en) | 2013-11-25 | 2020-10-13 | The Broad Institute, Inc. | Compositions and methods for diagnosing, evaluating and treating cancer |
| GB201321242D0 (en) * | 2013-12-02 | 2014-01-15 | Immune Targeting Systems Its Ltd | Immunogenic compound |
| US11725237B2 (en) | 2013-12-05 | 2023-08-15 | The Broad Institute Inc. | Polymorphic gene typing and somatic change detection using sequencing data |
| NZ721908A (en) | 2013-12-20 | 2022-12-23 | Massachusetts Gen Hospital | Combination therapy with neoantigen vaccine |
| EP4636401A2 (en) | 2014-12-19 | 2025-10-22 | The Broad Institute, Inc. | Methods for profiling the t-cell-receptor repertoire |
| US10975442B2 (en) | 2014-12-19 | 2021-04-13 | Massachusetts Institute Of Technology | Molecular biomarkers for cancer immunotherapy |
| KR102590454B1 (ko) | 2016-07-07 | 2023-10-17 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 항체-애쥬번트 접합체 |
| US11464854B2 (en) * | 2017-03-23 | 2022-10-11 | Children's Medical Center Corporation | Methods and compositions relating to adjuvants |
| CA3057715A1 (en) | 2017-04-04 | 2018-10-11 | Avidea Technologies, Inc. | Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response |
| WO2019040491A1 (en) | 2017-08-22 | 2019-02-28 | Dynavax Technologies Corporation | MODIFIED ALKYL CHAIN IMIDAZOQUINOLINE TLR7 / 8 AGONIST COMPOUNDS AND USES THEREOF |
| US10722591B2 (en) | 2017-11-14 | 2020-07-28 | Dynavax Technologies Corporation | Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and uses thereof |
| AU2019302562B2 (en) * | 2018-07-10 | 2026-02-19 | Seqirus Pty Ltd | Removal of agglomerates |
| JP2022525594A (ja) | 2019-03-15 | 2022-05-18 | ボルト バイオセラピューティクス、インコーポレーテッド | Ｈｅｒ２を標的とする免疫結合体 |
| CA3135913A1 (en) * | 2019-04-01 | 2020-10-08 | Altimmune Uk Ltd | Locally acting toll-like receptor 7 (tlr7) and/or tlr8 agonist immunotherapy compounds and their uses |
| WO2023085956A1 (en) * | 2021-11-09 | 2023-05-19 | Avalia Immunotherapies Limited | Novel therapeutic vaccines |
| TWI894573B (zh) * | 2022-06-09 | 2025-08-21 | 中央研究院 | Nod1調節劑及其用途 |
| US12531162B1 (en) * | 2023-05-31 | 2026-01-20 | Northeastern University | Multi-dimensional phenotypic space for genotype to phenotype mapping and intelligent design of cancer drug therapies using a deep learning net |
| US12562256B2 (en) * | 2023-11-07 | 2026-02-24 | New York University | Systems, methods and computer-accessible medium for identifying target pairs for CAR-T therapy |
| KR102784104B1 (ko) * | 2024-04-04 | 2025-03-24 | 대한민국(방위사업청장) | 이미퀴모드 및 Nod2 수용체 자극 성분 또는 박테리아를 포함하는 면역 어쥬번트 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4801575A (en) | 1986-07-30 | 1989-01-31 | The Regents Of The University Of California | Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| US5294605A (en) | 1990-07-19 | 1994-03-15 | The Scripps Research Institute | Amphiphilic peptide compositions and analogues thereof |
| FR2744123B1 (fr) * | 1996-01-26 | 1998-04-17 | Carelli Claude Marcel Henri | Molecules biologiquement actives plus particulierement peptidiques ayant un effet potentialisateur de l'activite biologique de l'hormone de croissance |
| CA2467828C (en) | 2001-11-29 | 2011-10-04 | 3M Innovative Properties Company | Pharmaceutical formulations comprising an immune response modifier |
| US7427629B2 (en) | 2002-08-15 | 2008-09-23 | 3M Innovative Properties Company | Immunostimulatory compositions and methods of stimulating an immune response |
| CN1906192A (zh) | 2003-11-14 | 2007-01-31 | 3M创新有限公司 | 羟胺取代的咪唑环化合物 |
| GB0716992D0 (en) | 2007-08-31 | 2007-10-10 | Immune Targeting Systems Its L | Influenza antigen delivery vectors and constructs |
| GB0408164D0 (en) | 2004-04-13 | 2004-05-19 | Immune Targeting Systems Ltd | Antigen delivery vectors and constructs |
| JP2008539252A (ja) * | 2005-04-25 | 2008-11-13 | スリーエム イノベイティブ プロパティズ カンパニー | 免疫活性化組成物 |
| ES2456964T3 (es) | 2007-02-07 | 2014-04-24 | The Regents Of The University Of California | Conjugados de agonistas de TLR sintéticos y usos de los mismos |
| RS53872B2 (sr) * | 2008-05-14 | 2018-06-29 | Immatics Biotechnologies Gmbh | Novi i snažni mhc peptidi klase ii izvedeni iz survivina i neurokana |
| MX2011004249A (es) | 2008-10-24 | 2011-07-20 | Glaxosmithkline Biolog Sa | Derivados de imidazoquinolina lipidados. |
| WO2010089019A1 (en) * | 2009-01-14 | 2010-08-12 | Andre Koltermann | Compounds comprising n-formyl-methionine residues and tumor-targeting peptides |
| EP2507237A1 (en) | 2009-12-03 | 2012-10-10 | Dainippon Sumitomo Pharma Co., Ltd. | Imidazoquinolines which act via toll - like receptors (tlr) |
| US8916162B2 (en) | 2010-02-20 | 2014-12-23 | Alexey Gennadievich Zdanovsky | Botulinum neurotoxin antigenic compositions and methods |
| LT2606047T (lt) | 2010-08-17 | 2017-04-10 | 3M Innovative Properties Company | Imuninio atsako modifikatoriaus junginio lipidizuotos kompozicijos, sudėtys ir būdai |
| GB201022147D0 (en) * | 2010-12-31 | 2011-02-16 | Immune Targeting Systems Its Ltd | Formulation |
| WO2012113413A1 (en) * | 2011-02-21 | 2012-08-30 | Curevac Gmbh | Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates |
| US8728486B2 (en) | 2011-05-18 | 2014-05-20 | University Of Kansas | Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds |
| EP2717919B1 (en) | 2011-06-03 | 2016-08-03 | 3M Innovative Properties Company | Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom |
| GB201321242D0 (en) * | 2013-12-02 | 2014-01-15 | Immune Targeting Systems Its Ltd | Immunogenic compound |
-
2013
- 2013-12-02 GB GBGB1321242.8A patent/GB201321242D0/en not_active Ceased
-
2014
- 2014-12-02 CN CN201480071742.1A patent/CN105873638A/zh active Pending
- 2014-12-02 WO PCT/GB2014/053577 patent/WO2015082905A1/en not_active Ceased
- 2014-12-02 US US15/100,800 patent/US9962453B2/en active Active
- 2014-12-02 EP EP14809960.9A patent/EP3077052A1/en not_active Withdrawn
- 2014-12-02 EA EA201691146A patent/EA201691146A1/ru unknown
- 2014-12-02 CA CA2931933A patent/CA2931933A1/en active Pending
- 2014-12-02 KR KR1020167017734A patent/KR102356869B1/ko not_active Expired - Fee Related
- 2014-12-02 JP JP2016555933A patent/JP6792452B2/ja not_active Expired - Fee Related
- 2014-12-02 BR BR112016012528A patent/BR112016012528A2/pt not_active IP Right Cessation
-
2018
- 2018-05-02 US US15/968,839 patent/US10434183B2/en not_active Expired - Fee Related
-
2019
- 2019-10-07 US US16/595,311 patent/US10849984B2/en not_active Expired - Fee Related
-
2020
- 2020-11-06 US US17/091,106 patent/US20210145975A1/en not_active Abandoned
- 2020-11-06 JP JP2020185572A patent/JP7095053B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7095053B2 (ja) | 免疫原性化合物 | |
| CN103402539B (zh) | 一种用于产生对抗病原体的持久免疫和保护的合成免疫原 | |
| Azmi et al. | Recent progress in adjuvant discovery for peptide-based subunit vaccines | |
| Fifis et al. | Short peptide sequences containing MHC class I and/or class II epitopes linked to nano-beads induce strong immunity and inhibition of growth of antigen-specific tumour challenge in mice | |
| KR102239207B1 (ko) | 장내 병원균에 대한 면역 반응을 증진시키는 조성물 및 방법 | |
| CN110279853A (zh) | 包含聚合载体货物复合物和至少一种蛋白或肽抗原的药物组合物 | |
| JP5775451B2 (ja) | インフルエンザを処置するための組成物および方法 | |
| Keijzer et al. | Inactivated influenza vaccine adjuvanted with bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion | |
| JP2015530413A (ja) | 改良されたワクチン組成物および使用方法 | |
| WO2019213555A1 (en) | Artificial promiscuous t helper cell epitopes that facilitate targeted antibody production with limited t cell inflammatory response | |
| US20090214598A1 (en) | Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease | |
| JP7561182B2 (ja) | ペプチドがロードされたキャリアシステムおよびその使用 | |
| Tohumeken et al. | A modular antigen presenting peptide/oligonucleotide nanostructure platform for inducing potent immune response | |
| US20220332770A1 (en) | High-Density Flagellin-Displaying Virus-Like Particle As Vaccine Carrier | |
| US20230109142A1 (en) | Corona virus vaccine | |
| Zeng et al. | Soluble Proteins Induce Strong CD8+ T Cell | |
| HK1130687A (en) | Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease |